Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

National automated surveillance of hospital onset bacteraemia and fungaemia using data from the national antimicrobial resistance surveillance system: a retrospective exploratory evaluation, the Netherlands, 2018 to 2023

Дата публикации: 16-07-2026 00:00:00


BACKGROUND
Hospital-onset bacteraemia and fungaemia (HOB) is a new target for automated surveillance of healthcare-associated infections.
AIM
We aimed to evaluate (i) whether data from a national laboratory-based antimicrobial resistance (AMR) surveillance system (ISIS-AR) are a suitable source for fully automated HOB surveillance and (ii) whether the derived HOB rates from automated surveillance are a useful measure for national surveillance.
METHODS
We applied an algorithm based on a consensus HOB definition to ISIS-AR data from 2018 to 2023. We performed: (i) technical evaluation of the data to determine their suitability for automated HOB surveillance, (ii) outcome validation of automatically identified HOB cases in four hospitals, and (iii) qualitative interviews with stakeholders on the anticipated value of HOB surveillance.
RESULTS
Most parameters required for HOB identification were present, except for hospital admission dates (≥ 80% available in only 14 hospitals). Outcome validation showed accurate identification of HOBs caused by pathogens (non-commensals), but identification of HOBs caused by common commensals varied between hospitals, reflecting laboratory policy differences. Interviewees emphasised that feedback from national HOB surveillance to hospitals can be valuable for monitoring local trends, as signal for in-depth investigations and benchmarking.
CONCLUSION
Dutch national automated HOB surveillance based on secondary use of national AMR surveillance data for pathogen-related HOBs is feasible, particularly if recording admission date is improved. Understanding local routine care and diagnostic practices is crucial for the interpretation of results. The main usefulness is expected at hospital level, while its value for national trend monitoring needs further study.


Основное содержимое страницы с новостью.

  1. Home
  2. Eurosurveillance
  3. Volume 31, Issue 28, 16/Jul/2026
  4. Article

Research Open Access

http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2026.31.28.2500881

Like 0

Access full text Article

Abstract

BACKGROUND

Hospital-onset bacteraemia and fungaemia (HOB) is a new target for automated surveillance of healthcare-associated infections.

AIM

We aimed to evaluate (i) whether data from a national laboratory-based antimicrobial resistance (AMR) surveillance system (ISIS-AR) are a suitable source for fully automated HOB surveillance and (ii) whether the derived HOB rates from automated surveillance are a useful measure for national surveillance.

METHODS

We applied an algorithm based on a consensus HOB definition to ISIS-AR data from 2018 to 2023. We performed: (i) technical evaluation of the data to determine their suitability for automated HOB surveillance, (ii) outcome validation of automatically identified HOB cases in four hospitals, and (iii) qualitative interviews with stakeholders on the anticipated value of HOB surveillance.

RESULTS

Most parameters required for HOB identification were present, except for hospital admission dates (≥ 80% available in only 14 hospitals). Outcome validation showed accurate identification of HOBs caused by pathogens (non-commensals), but identification of HOBs caused by common commensals varied between hospitals, reflecting laboratory policy differences. Interviewees emphasised that feedback from national HOB surveillance to hospitals can be valuable for monitoring local trends, as signal for in-depth investigations and benchmarking.

CONCLUSION

Dutch national automated HOB surveillance based on secondary use of national AMR surveillance data for pathogen-related HOBs is feasible, particularly if recording admission date is improved. Understanding local routine care and diagnostic practices is crucial for the interpretation of results. The main usefulness is expected at hospital level, while its value for national trend monitoring needs further study.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2026.31.28.2500881

2026-07-16

2026-07-27

Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/31/28/eurosurv-31-28-2.html?itemId=/content/10.2807/1560-7917.ES.2026.31.28.2500881&mimeType=html&fmt=ahah

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Epidemiology of Mycoplasma pneumoniae and co-detection with other respiratory pathogens in a respiratory sentinel surveillance system in Scotland, October 2022 to May 2025011.6523-07-2026
2Perspective on human diagnostic and national reference laboratory preparedness for zoonotic influenza in Europe07.709-07-2026
3Integrated Epidemiologic and Genomic Surveillance of Carbapenemase-Producing Enterobacterales in a Regional Healthcare Network0516-07-2026
4Risk factors for multidrug-resistant organism infection in patients with postoperative pneumonia: a retrospective analysis of 333 cases at a tertiary grade-A hospital0516-07-2026
5Bakterier vid infektion kan snabbt spåras med lovande metod5718-06-2026
6Trends in syphilis, gonorrhoea and chlamydia: a descriptive analysis of national surveillance data, Poland, 2013 to 2024011.6616-07-2026
7Authors’ response: Seasonality and effects of climatic exposures on community-acquired Legionnaires’ disease incidence, Italy, 2005 to 2023026.6723-07-2026
8Human infections with Dermatophilus sp.: travel-associated first case and a local cluster in the context of emerging European outbreaks, Basel, Switzerland, 2025 to 2026013.8723-07-2026
9Rectal Colonization with Carbapenem-Resistant Enterobacterales in Intensive Care Unit Patients: Prevalence, Clinical Outcomes, and Risk of Subsequent Infection0714-07-2026
10Rgg/SHP transcriptional regulators, RaS-RiPPs, and their impacts in streptococci [version 2; peer review: 1 approved, 2 approved with reservations]5803-06-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.79. Источник: www.eurosurveillance.org.